Mosaic ImmunoEngineering (CPMV) Liabilities and Shareholders Equity (2011 - 2026)
Mosaic ImmunoEngineering's Liabilities and Shareholders Equity was $9,828 in Q1 2026, down 89.9% from $97,784 a year earlier and down 50.6% from the prior quarter.
Powered by 
Analysis
Mosaic ImmunoEngineering (CPMV) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
At the end of FY2025, Liabilities and Shareholders Equity at Mosaic ImmunoEngineering came in at $19,882, down 86.0% from FY2024.
- Liabilities and Shareholders Equity has now declined for five consecutive years, with a five-year compound annual growth rate of -46.6% (FY2020 to FY2025).
- In earlier years, Liabilities and Shareholders Equity was $141,611 in FY2024 (-21.1%), $179,533 in FY2023 (-31.3%), $261,277 in FY2022 (-3.0%) and $269,494 in FY2021 (-41.1%).
- The Q1 2026 figure marks the lowest quarterly Liabilities and Shareholders Equity in data going back to Q1 2021.
- Compared with a year earlier, Liabilities and Shareholders Equity was higher in three of the last eight quarters, with growth averaging 6.6%.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q2 2025 (growth of 370.0%); the worst was Q2 2024 (a decline of 96.7%).
- Per Business Quant data, CPMV's Liabilities and Shareholders Equity in the three quarters before Q1 2026 was $19,882 (Q4 2025), $55,298 (Q3 2025) and $57,699 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Mosaic ImmunoEngineering | 434,528.21 | 434,528.21 | - | 9,828.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 9,828.00 |
| Dec 31, 2025 | 19,882.00 |
| Sep 30, 2025 | 55,298.00 |
| Jun 30, 2025 | 57,699.00 |
| Mar 31, 2025 | 97,784.00 |
| Dec 31, 2024 | 141,611.00 |
| Sep 30, 2024 | 39,950.00 |
| Jun 30, 2024 | 12,277.00 |
| Mar 31, 2024 | 78,952.00 |
| Dec 31, 2023 | 179,533.00 |
| Sep 30, 2023 | 285,528.00 |
| Jun 30, 2023 | 369,363.00 |
| Mar 31, 2023 | 148,469.00 |
| Dec 31, 2022 | 261,277.00 |
| Sep 30, 2022 | 432,927.00 |
| Jun 30, 2022 | 223,151.00 |
| Mar 31, 2022 | 403,590.00 |
| Dec 31, 2021 | 269,494.00 |
| Sep 30, 2021 | 445,657.00 |
| Jun 30, 2021 | 602,329.00 |
API Access
Mosaic ImmunoEngineering Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CPMV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CPMV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CPMV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();